Pages that link to "Q45405023"
Jump to navigation
Jump to search
The following pages link to Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H. (Q45405023):
Displaying 13 items.
- Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy (Q33417353) (← links)
- Acute hepatitis B of genotype H resulting in persistent infection (Q37654485) (← links)
- Management of treatment failure in chronic hepatitis B. (Q37980893) (← links)
- Diagnostic and therapeutic progress of multi-drug resistance with anti-HBV nucleos(t)ide analogues (Q38074646) (← links)
- Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus (Q38966123) (← links)
- Primary resistance, multidrug resistance, and cross-resistance pathways in HBV as a consequence of treatment failure (Q41989421) (← links)
- Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B. (Q42174492) (← links)
- Partial virological response to three different nucleotide analogues in naive patients with chronic hepatitis B. (Q42177613) (← links)
- Analogs combination therapy in chronic hepatitis B: when and how? (Q42795327) (← links)
- Clinical and virological effects of long-term (over 5 years) lamivudine therapy (Q43158113) (← links)
- Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection (Q45398766) (← links)
- Is it possible to predict the development of an entecavir resistance mutation in patients with chronic hepatitis B in clinical practice? (Q48190133) (← links)
- Long-term outcome of entecavir treatment of nucleos(t)ide analogue-naïve chronic hepatitis B patients in Japan (Q59354057) (← links)